Method for the prevention and control of epileptic seizure associated with Lennox-Gastaut syndrome
First Claim
Patent Images
1. A method for the prevention and control of seizures associated with Lennox-Gastaut syndrome which comprises administering to a warm-blooded animal in need of such treatment 2-phenyl-1,3-propanediol dicarbamate in a daily dosage of from about 100 milligrams to about 5 grams.
6 Assignments
0 Petitions
Accused Products
Abstract
A novel method for the prevention and control of epileptic seizures, particularly intractable seizures associated with the Lennox-Gastaut syndrome, employing pharmaceutical compositions containing 2-phenyl-1,3-propanediol dicarbamate.
76 Citations
1 Claim
-
1. A method for the prevention and control of seizures associated with Lennox-Gastaut syndrome which comprises administering to a warm-blooded animal in need of such treatment 2-phenyl-1,3-propanediol dicarbamate in a daily dosage of from about 100 milligrams to about 5 grams.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
-
Current AssigneeMeda Pharmaceuticals Incorporated (Mylan N.V.)
-
Original AssigneeCarter-Wallace Incorporated
-
InventorsSofia, Robert D.
-
Primary Examiner(s)FRIEDMAN, STANLEY
-
Application NumberUS07/966,964Time in Patent Office498 DaysField of Search514/534US Class Current514/534CPC Class CodesA61K 31/27 of carbamic or thiocarbamic...
